002742 logo

Chongqing Sansheng Industrial Co.,Ltd. Stock Price

SZSE:002742 Community·CN¥2.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

002742 Share Price Performance

CN¥0
-4.34 (-100.00%)
CN¥0
-4.34 (-100.00%)
Price CN¥0

002742 Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Slightly overvalued with imperfect balance sheet.

2 Risks
0 Rewards

Chongqing Sansheng Industrial Co.,Ltd. Key Details

CN¥946.7m

Revenue

CN¥803.7m

Cost of Revenue

CN¥143.0m

Gross Profit

CN¥930.9m

Other Expenses

-CN¥787.9m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-1.82
15.11%
-83.22%
-363.2%
View Full Analysis

About 002742

Founded
2002
Employees
1550
CEO
Zhi Qiang Zhang
WebsiteView website
www.cqssgf.com

Chongqing Sansheng Industrial Co.,Ltd. develops, produces and sells building materials and chemicals in China and internationally. It operates through two segments, Buildings Materials Chemical Industry; and Pharmaceutical Manufacturing. The company offers commercial concrete, water reducing agents, and expansion agents for industrial and civil buildings, highways, railways, bridges, tunnels, airports, water conservancy, and hydropower; and sulfuric acid for the production of fertilizers, chemicals, light industry, textile, steel, water reducer, and other non-fertilizer acid enterprises; and concrete admixtures. It also provides pharmaceutical intermediates, such as procaine hydrochloride, cefoxitin acid intermediates, chlorine intermediates, chloramphenicol intermediates, aztreonam intermediates, and orlistat intermediates used in antibiotic drugs, anti-hepatitis C drugs, diabetes drugs, benzathine penicillin and cefoxitin, procaine penicillin, and cosmetics; and API products, including acetaminophen, cloperidine hydrochloride, levofloxacin mesylate, benolate, and diphenhydramine hydrochloride. In addition, the company offers preparation products comprising compound acetaminophen and diphenhydramine tablets, cloperidin hydrochloride tablets, clarithromycin sustained-release tablets, diclofenac sodium enteric-coated tablets, acetaminophen tablets, and famotidine tablets used in antipyretic and analgesic, antiviral, antibacterial, cough, allergy, local anesthesia; and famotidine, diclofenac sodium, nifedipine, acetaminophen, furosemide, norfloxacin used in clinical drugs to meet basic drug needs. The company was formerly known as Chongqing Sansheng Special Building Materials Co., Ltd. and changed its name to Chongqing Sansheng Industrial Co.,Ltd. in October 2016. Chongqing Sansheng Industrial Co.,Ltd. was incorporated in 2002 and is headquartered in Chongqing, China.

Recent 002742 News & Updates

Recent updates

No updates